Abstract
All clinicians must have a measuring tape on their desk. This is as important as having a blood pressure metre and scales in their office. If the metabolic syndrome is suspected, waist circumference must be measured. This must be done in patients at high risk, see Fig. 15.1. If increased waist circumference is measured, serum triglyceride, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol and fasting plasma glucose must also be measured. Based on these measurements, the diagnosis “metabolic syndrome” can be made, and a formal basis for intervention is obtained. The International Diabetes Federation (IDF) has recently formulated a definition of the metabolic syndrome, and we recommend using this definition in clinical practice [1].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Alberti KGMM, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition A Consensus Statement from the International Diabetes Federation. Diabet Med 23:469–480
Beck-Nielsen H, Pedersen O, Lindskov HO (1979) Normalization of the insulin sensitivity and the cellular insulin binding during treatment of obese diabetics for one year. Acta Endocrinol (Copenh) 90:103–112
Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J (2003) The Finnish Diabetes Prevention Study (DPS). Diabetes Care 26:3230–3236
Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S (2005) The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 142:611–619
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Aunola S, Cepaitis Z, Moltchanov V, Hakumaki M, Mannelin M, Martikkala V, Sundvall J (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403
Richelsen B (2007) Obesity and pharmacological treatment. In: Mogensen CE (ed) Pharmacotherapy of diabetes: new developments. Springer, New York, pp 167–172
Reaven GM (2007) The insulin resistance syndrome: concept and therapeutic approaches. In: Mogensen CE (ed) Pharmacotherapy of diabetes: new developments. Springer, New York, pp 19–30
Laakso M, Lehto S (1997) Epidemiology of macrovascular disease in diabetes. Diabetes Rev 5:294–315
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this chapter
Cite this chapter
Beck-Nielsen, H. (2013). Treatment of the Metabolic Syndrome in Daily Clinical Practice: Algorithms. In: Beck-Nielsen, H. (eds) The Metabolic Syndrome. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1331-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1331-8_15
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1330-1
Online ISBN: 978-3-7091-1331-8
eBook Packages: MedicineMedicine (R0)